Literature DB >> 8662295

Effect of metabolic alkalosis and metabolic acidosis on urinary kallikrein excretion of anaesthetized rats: evidence for a role of blood pH as regulator of renal kallikrein secretion.

M Marin-Grez1, P Vallés.   

Abstract

The effect of altering the acid-base status on urinary kallikrein excretion of barbiturate-anaesthetized rats was investigated. Alkalosis was induced in a group of rats by intravenous (i.v.) infusion of NaOH at 0.45 mmol x h(-1) for 30 min. Acidosis was induced in two groups of rats by i.v. infusion of HCl at 1.5 mmol x h(-1) for 30 min (uncompensated acidosis) or 0.15 mmol x h(-1) for 3 h (compensated acidosis), respectively. Time controls received 0.45 mmol x h(-1) NaCl. Rats with alkalosis excreted less kallikrein than their controls (P < 0.05). Rats with uncompensated acidosis excreted more active kallikrein (P < 0.05), whereas rats with compensated acidosis excreted similar amounts when compared with their respective controls. In rats with uncompensated acid-base derangements, the urinary kallikrein excreted per millilitre of glomerular filtrate was correlated with blood H+ activity (r = 0.99, P < 0.01). Arterial blood pressure, haematocrit, glomerular filtration rate, urine flow rate and Na+ and K+ excretions of experimental and control animals did not differ. Thus, renal kallikrein secretion into the tubular fluid appears to be regulated by blood proton activity. This, along with our previous demonstration that kallikrein inhibits HCO3- secretion into the tubular lumen (Renal Physiol 17:301-306, 1994; J Physiol (Lond) 488:163-170, 1995), indicates that this enzyme is part of a feedback loop regulating acid-base balance.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8662295     DOI: 10.1007/s004240050125

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  13 in total

1.  [A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics].

Authors:  J FUHR; J KACZMARCZYK; C D KRUTTGEN
Journal:  Klin Wochenschr       Date:  1955-08-01

2.  Effect of urinary pH and urine flow rate on prostaglandin E2 and kallikrein excretion by the conscious dog.

Authors:  J Filep; E Földes-Filep
Journal:  J Physiol       Date:  1987-02       Impact factor: 5.182

3.  Micropuncture localization of kallikrein secretion in the rat nephron.

Authors:  D Beasley; N B Oza; N G Levinsky
Journal:  Kidney Int       Date:  1987-07       Impact factor: 10.612

4.  Involvement of renal kallikrein in the regulation of bicarbonate excretion in rats.

Authors:  M Marin-Grez; P Vallés; P I Odigie
Journal:  J Physiol       Date:  1995-10-01       Impact factor: 5.182

5.  Relationship between the renal kallikrein activity and the urinary excretion of kallikrein in rats.

Authors:  M Marin-Grez; G Schaechtelin; G Bönner
Journal:  Experientia       Date:  1982-08-15

6.  Effect of changes in perfusion pressure on renal and urinary kallikrein in the isolated perfused rat kidney.

Authors:  G Bönner; U Schwertschlag; M Marin-Grez; F Gross
Journal:  Ren Physiol       Date:  1983

7.  Site of kininogenase secretion in the dog nephron.

Authors:  A G Scicli; O A Carretero; A Hampton; P Cortes; N B Oza
Journal:  Am J Physiol       Date:  1976-02

8.  Kallikrein (kininogenase) in the mouse nephron: effect of dietary potassium.

Authors:  W G Guder; J Hallbach; E Fink; B Kaissling; G Wirthensohn
Journal:  Biol Chem Hoppe Seyler       Date:  1987-06

9.  Lymphatic, renal, and urinary kallikreins in the rat.

Authors:  R Garcia; G Thibault; J Genest
Journal:  Am J Physiol       Date:  1984-07

10.  Evidence for an inhibitory effect of kallikrein on collecting duct bicarbonate secretion in rats and rabbits.

Authors:  M Marin-Grez; P Vallés
Journal:  Ren Physiol Biochem       Date:  1994 Nov-Dec
View more
  1 in total

1.  Role of perfusate hydrogen ion activity in kallikrein release from isolated rat kidneys.

Authors:  M Marin-Grez
Journal:  Pflugers Arch       Date:  1996-06       Impact factor: 3.657

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.